PTEN expression by an oncolytic herpesvirus lysed the bulk tumor mass while creating an ATP-rich immune stimulating microenvironment during infection and decreased PD-L1 expression on the surface of tumor cells after treatment, in a murine model of breast cancer with brain metastases and intracranial human GBM tumors in nude mice [96]. This evidence concerns the gene PTEN and breast cancer.